Jarlego, Cliff S.
HRN: 23 23 12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/05/2023
07/11/2023
ORAL- SWISH AND SWALLOW
5 Ml
Q6
Oral Thrush
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes